Suppr超能文献

CT引导下经皮射频消融治疗骨样骨瘤:采用优化技术对结果进行重新评估及中期随访中的可能疼痛模式

CT-guided percutaneous radiofrequency ablation in osteoid osteoma: re-assessments of results with optimized technique and possible pain patterns in mid-term follow-up.

作者信息

Omlor G, Merle C, Lehner B, Ewerbeck V, Rehnitz C, Weber M-A, Ludwig K

机构信息

Orthopädische Universitätsklinik, Universitätsklinik Heidelberg.

出版信息

Rofo. 2012 Apr;184(4):333-9. doi: 10.1055/s-0031-1299121. Epub 2012 Jan 23.

Abstract

PURPOSE

To re-assess radiofrequency ablation (RFA) of osteoid osteoma (OO) with an optimized technique and to evaluate patterns of post-interventional pain important for the detection of recurrence.

MATERIALS AND METHODS

44 consecutive patients with OO treated with precise inclusion criteria by RFA were examined retrospectively. RFA was performed with an optimized technique. Technical success (TS), primary and secondary clinical success (PCS/SCS) and minor and major complications (MIC/MAC) were evaluated. Pain patterns defined as "osteoid osteoma-specific pain" (OOSP) and "unspecific pain" (UP), "limitations in daily activity" (LDA) and "patient satisfaction" (PS) were evaluated using a numeric rating scale (0 - 10; 0 = no pain, 0 = no limitation, 10 = fully satisfied). The pain intensity before and after RFA was compared. The mean follow-up time was 35 months (n = 40, range 2 - 60 months).

RESULTS

TS was 100 % (n = 44), PCS 98 % (n = 44), and SCS 100 % (n = 40). MIC and MAC were 0 % (n = 44). OOSP was 0 after RFA in all 44 patients. UP was 0 in 24 of 40 patients (60 %), 1 in 11 patients (28 %) for up to 7 days and 1 - 4 in 5 patients (13 %) for 30 - 180 days. LDA was 0 in 39 of 40 patients (98 %), and 1 in 1 patient. PS was 10 in all patients. The pain after RFA was significantly less than before RFA (p < 0.0001).

CONCLUSION

Using an optimized technique primary clinical success rates in the high nineties have to be expected. Unspecific pain of low intensity is not unusual after RFA and has to be distinguished from pain caused by recurrent disease.

摘要

目的

采用优化技术重新评估骨样骨瘤(OO)的射频消融(RFA),并评估对复发检测至关重要的介入后疼痛模式。

材料与方法

回顾性检查44例采用精确纳入标准经RFA治疗的连续性骨样骨瘤患者。采用优化技术进行RFA。评估技术成功率(TS)、初次和二次临床成功率(PCS/SCS)以及轻微和严重并发症(MIC/MAC)。使用数字评分量表(0 - 10;0 = 无疼痛,0 = 无限制,10 = 完全满意)评估定义为“骨样骨瘤特异性疼痛”(OOSP)和“非特异性疼痛”(UP)、“日常活动受限”(LDA)和“患者满意度”(PS)的疼痛模式。比较RFA前后的疼痛强度。平均随访时间为35个月(n = 40,范围2 - 60个月)。

结果

TS为100%(n = 44),PCS为98%(n = 44),SCS为100%(n = 40)。MIC和MAC为0%(n = 44)。44例患者RFA后OOSP均为0。40例患者中有24例(60%)UP为0,11例患者(28%)在长达7天内UP为1,5例患者(13%)在30 - 180天内UP为1 - 4。40例患者中有39例(98%)LDA为0,1例患者LDA为1。所有患者的PS均为10。RFA后的疼痛明显低于RFA前(p < 0.0001)。

结论

采用优化技术时,初次临床成功率有望达到近90%以上。RFA后出现低强度的非特异性疼痛并不罕见,必须与复发性疾病引起的疼痛相区分。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验